Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly bortezomib-based BCD regimen in elderly transplant-ineligible newly diagnosed multiple myeloma
ChiCTR-OPC-15006337Phase 4Completed
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bortezomib, cyclophosphamide and dexamethasone in multiple myeloma (MM), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: response rate. Started Mar 2010; status: completed.
02
Drugs
bortezomibcyclophosphamidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR-OPC-15006337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006337.